Support clinical decisions with data. Ventica is a smart and simple tool detecting bronchial obstruction in children under six years with recurrent wheeze. Read more about our solution from the…
Ventica’s Clinical Advisor, Prof. Mika Mäkelä from Helsinki University Hospital, answered our questions about treating young children with asthma-like symptoms and he’s experiences with Ventica. Read the interview here: The…
Recent studies show how Ventica provides an unprecedented, objective view of young children’s lung function with recurrent respiratory symptoms (https://www.ventica.net/references/). Still more clinical data is needed and now we have…
Ventica has now been recognized for the first time as a promising lung function test for infants by an international task force. The task force is preparing the EAACI Clinical…
Re-thinking lung function testing in young children Thursday, December 3rd 2020 at 9:00 am (CET) Objective information is hard to come by and often missing from personalized treatment decisions in…
Mediuutiset, a Finnish healthcare news media, writes about the revolution in children’s asthma measurement. The big question has been how to measure the symptoms at home and especially at night-time….
New clinical study shows that a low Ventica EVI test result is associated with wheeze, impaired lung function, and higher risk of developing asthma in infants aged 6-23 months. These…
A new clinical study on the Ventica® EVI® parameter will be published in Pediatric Allergy and Immunology (PAI). The study shows that low EVI is strongly associated with lower airway…
We would like to sincerely extend our thoughts and best wishes to all impacted by COVID-19. The safety and health of our employees, business partners and customers is of vital…
